[Effects of tamoxifen and oxyprogesterone caproate on steroid hormone receptors in tumors and indicators of reproductive homeostasis in patients with cancer of the uterine body].
Vishnevskiĭ
A S
AS
Bokhman
Ia V
IaV
Tsyrlina
E V
EV
Bobrov
Iu F
IuF
Shtofmakher
I A
IA
D000077713:17 alpha-Hydroxyprogesterone Caproate; D000328:Adult; D004717:Endometrium / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D006065:Gonadotropins, Pituitary / Q000378:metabolism; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D008875:Middle Aged; D011388:Prolactin / Q000378:metabolism; D011959:Receptors, Estradiol / Q000187:drug effects* / Q000378:metabolism; D011980:Receptors, Progesterone / Q000187:drug effects* / Q000378:metabolism; D013629:Tamoxifen / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D006065:Gonadotropins, Pituitary; D006908:Hydroxyprogesterones; D011959:Receptors, Estradiol; D011980:Receptors, Progesterone; D013629:Tamoxifen; D000077713:17 alpha-Hydroxyprogesterone Caproate; D011388:Prolactin
Vliianie tamoksifena i oksiprogesterona kapronata na retseptory steroidnykh gormonov v opukholi i pokazateli reproduktivnogo gomeostaza u bol'nykh rakom tela matki.